Risks Associated with SGLT2 Inhibitors: An Overview

Current Drug Safety
Mahakpreet Singh, Anoop Kumar

Abstract

Sodium glucose co-transport 2 inhibitors (SGLT2-i) are the new class of antidiabetic medications which are recently approved (2013) by the Food and Drug Administration (FDA) for the treatment of diabetes. These inhibitors block the SGLT2 protein which involved glucose reabsorption from proximal renal tubule resulting in increased glucose excretion and lower blood glucose levels. These inhibitors exert favourable effects beyond glucose control such as consistent body weight, blood pressure and serum uric acid reductions. Canagliflozin, Dapagliflozin and empagliflozin belong to the class of SGLT2 inhibitors. All these drugs are giving promising results in the treatment of diabetes mellitus, but emerging data from post-marketing studies indicate their adverse effects such as diabetic ketoacidosis, genital and urinary tract infection, cancer, bone fracture and foot and leg amputation. Thus, there is a need for better understanding the risk profile of SGLT2 inhibitors. In this review, we have compiled the risk profile of SGLT2 inhibitors by collecting information from various sources such as case reports, published literature and from various regulatory websites. Further, the proposed mechanism of risks has also been discussed.

Citations

Jul 22, 2018·Expert Review of Clinical Pharmacology·Junyi Yang
Feb 14, 2019·Postgraduate Medicine·Theodosios D FilippatosMoses S Elisaf
Feb 8, 2019·Current Drug Safety·Mahakpreet SinghAnoop Kumar
Jun 20, 2019·Medicina·Carlo GarofaloLuca De Nicola
Mar 1, 2020·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Rebecca N JeromeJill M Pulley
Apr 2, 2019·Expert Opinion on Drug Safety·André J Scheen
Feb 23, 2020·Minerva cardioangiologica·Luca Di LulloSilvio Settembrini
Feb 1, 2020·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jose Luis GórrizMaria Jose Soler
Oct 28, 2020·Annals of Medicine·Emily BrownDaniel J Cuthbertson
Jan 23, 2021·Journal of the American College of Cardiology·Lee R Goldberg
Jan 14, 2021·Journal of Gastroenterology and Hepatology·Lampros ChrysavgisEvangelos Cholongitas
Mar 5, 2021·Life Sciences·Arpita AroraSimona Bungau
Feb 23, 2021·Asian Journal of Pharmaceutical Sciences·Yannis V SimosDimitrios Peschos
Dec 16, 2020·Clinical and Molecular Hepatology·Karn WijarnpreechaDonghee Kim
Jul 3, 2021·Journal of Clinical Medicine·Vicente Martínez-VizcaínoIván Cavero-Redondo
Jul 31, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Mohamed A MorsyYasmine F Ibrahim
May 19, 2021·Journal of Cardiovascular Pharmacology·Georgia AnastasiouEvangelos Liberopoulos
Jul 29, 2021·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Tapan BehlSimona Bungau
Aug 28, 2021·Antioxidants·Kai-Fan TsaiChien-Te Lee
Sep 12, 2021·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Manqiu MoNing Xia

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.